Detalhe da pesquisa
1.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096887
2.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
3.
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Leukemia
; 37(2): 339-347, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36566271
4.
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
J Hematol Oncol
; 14(1): 126, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404440
5.
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Leukemia
; 34(9): 2354-2363, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32647324
6.
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Leukemia
; 37(2): 504, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635392
7.
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.
Exp Hematol Oncol
; 9(1): 37, 2020 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33339537